These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11844676)

  • 1. Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.
    Sawa M; Kondo H; Nishimura S
    Bioorg Med Chem Lett; 2002 Feb; 12(4):581-4. PubMed ID: 11844676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of selective phosphonamide-based inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).
    Sawa M; Kurokawa K; Inoue Y; Kondo H; Yoshino K
    Bioorg Med Chem Lett; 2003 Jun; 13(12):2021-4. PubMed ID: 12781187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling.
    Park HI; Jin Y; Hurst DR; Monroe CA; Lee S; Schwartz MA; Sang QX
    J Biol Chem; 2003 Dec; 278(51):51646-53. PubMed ID: 14532275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results.
    Kontogiorgis CA; Papaioannou P; Hadjipavlou-Litina DJ
    Curr Med Chem; 2005; 12(3):339-55. PubMed ID: 15723623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1.
    Zhang X; Gonnella NC; Koehn J; Pathak N; Ganu V; Melton R; Parker D; Hu SI; Nam KY
    J Mol Biol; 2000 Aug; 301(2):513-24. PubMed ID: 10926524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the variability of the S1' pocket to improve matrix metalloproteinase inhibitor selectivity profiles.
    Gimeno A; Beltrán-Debón R; Mulero M; Pujadas G; Garcia-Vallvé S
    Drug Discov Today; 2020 Jan; 25(1):38-57. PubMed ID: 31513929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors.
    Lovejoy B; Welch AR; Carr S; Luong C; Broka C; Hendricks RT; Campbell JA; Walker KA; Martin R; Van Wart H; Browner MF
    Nat Struct Biol; 1999 Mar; 6(3):217-21. PubMed ID: 10074939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of human neutrophil collagenase reveals large S1' specificity pocket.
    Stams T; Spurlino JC; Smith DL; Wahl RC; Ho TF; Qoronfleh MW; Banks TM; Rubin B
    Nat Struct Biol; 1994 Feb; 1(2):119-23. PubMed ID: 7656015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.
    Sawa M; Kiyoi T; Kurokawa K; Kumihara H; Yamamoto M; Miyasaka T; Ito Y; Hirayama R; Inoue T; Kirii Y; Nishiwaki E; Ohmoto H; Maeda Y; Ishibushi E; Inoue Y; Yoshino K; Kondo H
    J Med Chem; 2002 Feb; 45(4):919-29. PubMed ID: 11831904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of ferulic Acid amides as selective matrix metalloproteinase inhibitors.
    Shi ZH; Li NG; Shi QP; Tang H; Tang YP; Li W; Yin L; Yang JP; Duan JA
    Med Chem; 2013 Nov; 9(7):947-54. PubMed ID: 23061601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.
    Hurst DR; Schwartz MA; Jin Y; Ghaffari MA; Kozarekar P; Cao J; Sang QX
    Biochem J; 2005 Dec; 392(Pt 3):527-36. PubMed ID: 16026329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity.
    Finzel BC; Baldwin ET; Bryant GL; Hess GF; Wilks JW; Trepod CM; Mott JE; Marshall VP; Petzold GL; Poorman RA; O'Sullivan TJ; Schostarez HJ; Mitchell MA
    Protein Sci; 1998 Oct; 7(10):2118-26. PubMed ID: 9792098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.
    Huang A; Joseph-McCarthy D; Lovering F; Sun L; Wang W; Xu W; Zhu Y; Cui J; Zhang Y; Levin JI
    Bioorg Med Chem; 2007 Sep; 15(18):6170-81. PubMed ID: 17606376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural bases for substrate and inhibitor recognition by matrix metalloproteinases.
    Aureli L; Gioia M; Cerbara I; Monaco S; Fasciglione GF; Marini S; Ascenzi P; Topai A; Coletta M
    Curr Med Chem; 2008; 15(22):2192-222. PubMed ID: 18781944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily.
    Fabre B; Filipiak K; Díaz N; Zapico JM; Suárez D; Ramos A; de Pascual-Teresa B
    Chembiochem; 2014 Feb; 15(3):399-412. PubMed ID: 24449516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validating the 1,2-Difluoro Motif As a Hybrid Bioisostere of CF
    Erdeljac N; Thiehoff C; Jumde RP; Daniliuc CG; Höppner S; Faust A; Hirsch AKH; Gilmour R
    J Med Chem; 2020 Jun; 63(11):6225-6237. PubMed ID: 32379447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design.
    Grams F; Reinemer P; Powers JC; Kleine T; Pieper M; Tschesche H; Huber R; Bode W
    Eur J Biochem; 1995 Mar; 228(3):830-41. PubMed ID: 7737183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.
    Reiter LA; Rizzi JP; Pandit J; Lasut MJ; McGahee SM; Parikh VD; Blake JF; Danley DE; Laird ER; Lopez-Anaya A; Lopresti-Morrow LL; Mansour MN; Martinelli GJ; Mitchell PG; Owens BS; Pauly TA; Reeves LM; Schulte GK; Yocum SA
    Bioorg Med Chem Lett; 1999 Jan; 9(2):127-32. PubMed ID: 10021913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).
    Graf von Roedern E; Brandstetter H; Engh RA; Bode W; Grams F; Moroder L
    J Med Chem; 1998 Jul; 41(16):3041-7. PubMed ID: 9685244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of the catalytic domain of human stromelysin-1 (MMP-3) and collagenase-3 (MMP-13) with a hydroxamic acid inhibitor SM-25453.
    Kohno T; Hochigai H; Yamashita E; Tsukihara T; Kanaoka M
    Biochem Biophys Res Commun; 2006 May; 344(1):315-22. PubMed ID: 16603129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.